Last reviewed · How we verify

NCT06323421: MindCRC

Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer

Completed NA Last updated 21 November 2025
What this trial tests

NA trial testing Mindfulness in Mindfulness in 24 participants. Completed in 31 August 2025.

Timeline
15 July 2024
Primary endpoint
15 July 2025
31 August 2025

Quick facts

Lead sponsorUniversity of Illinois at Chicago
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment24
Start date15 July 2024
Primary completion15 July 2025
Estimated completion31 August 2025
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Chicago

Who can join

Adults 45 to 65, female only, with Mindfulness or Colon Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Many neighborhoods in Chicago experience daily exposure to stressors including economic inopportunity and violent crime in public spaces. There is mounting evidence that chronic psychosocial stress can facilitate carcinogenesis by modulating the gut microbiome and immune system. The proposed research aims to study the practice of mindfulness to mitigate CPS and reduce colorectal cancer risk factors among Black American women at elevated risk.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Design of a mindfulness intervention to reduce risk factors for colorectal cancer among at-risk Black women in Chicago.
    Lima Oliveira M, Lima NS, Khara Renaud G, Estrada A, et al · · 2024 · PMID 39417824 · DOI 10.1152/japplphysiol.00608.2024

Verify or expand the search:

Other trials of Mindfulness

Trials testing the same drug.

Other recruiting trials for Mindfulness

Currently open trials in the same condition.

Other University of Illinois at Chicago trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06323421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing